|
|
|
| Home > About SIRO > Management Team |
|
Dr. Ajit Nair
President, SIRO India
Dr. Ajit Nair is the President for SIRO Clinpharm in India. He provides leadership, vision and direction to the
growth of SIRO's operations in India and is focused on creating an efficient and responsive organization to
service the growing client pool at SIRO. He also supports the Chief Executive Officer in strategic issues
concerning integration across various operational geographies and global delivery mechanisms.
Dr. Nair’s leadership, clinical development insight and operational expertise have strengthened SIRO's culture of
innovation, expanded the company's offerings, and has brought new efficiencies, speed, scalability and
standardization to the business. His area of focus includes further strengthening client relationships, as well as
leveraging SIRO's leadership role in Indian clinical research to support the company's emergence as a leading
provider of transnational fast track -optimal cost clinical research solutions.
This is Dr. Nair’s second stint with SIRO. In his current role he joined SIRO from a senior leadership role at
Glenmark Pharmaceuticals, a top Indian pharma company where his responsibilities included clinical development of
New Chemical Entities (NCE), global CRO management encompassing clinical operations, clinical data management &
biometrics and drug safety for clinical studies outsourced. His understanding of the complexities of clinical
research in India provides further confidence to the growing list of MNC pharmaceutical and biotech clientele that
utilize SIRO’s India services.
Dr. Nair is an active member of the Indian Society for Clinical Research and has led several initiatives for the
development of the clinical research sector in India. He is a frequent speaker on issues related to clinical R&D
and is a widely recognized subject matter expert on all issues concerning drug development.
Before Glenmark, Dr. Nair served in challenging positions in Clinical Research Operations/Medical Services with
Novartis and Wockhardt. Dr. Nair is a pharmacist by training and has a PhD in Pharmacology from Mumbai
University.
|
|
